Participated · Series A · Feb 2026

constellr operates a space-based platform that captures high-resolution thermal infrared data, adding a behavioural insight layer to traditional radar and optical imaging for intelligence, surveillance and reconnaissance (ISR). The company’s technology enables earlier detection and independent verification of activity in contested or deceptive environments, exemplified by recent monitoring of maritime movements near Russia’s Rybachiy nuclear submarine base. As the only proven operational provider of such data in the European Union, constellr supplies defence and security forces with the ability to uncover hidden operations, track non-cooperative assets and anticipate deployments. Funding is being directed toward expanding its satellite constellation to provide broader global coverage and to build next-generation platforms capable of sub-5-metre resolution. The firm also aims to ensure secure, sovereign control over intelligence for European and allied customers, elevating its system to full defence-grade performance. Including the latest raise, constellr has secured a total of €75 million in funding to date.

Participated · Equity · Dec 2025

Founded in 2017, Automotus has built a computer-vision platform that lets municipalities and airports track curb activity, generate data analytics, and automate payments for commercial vehicles, ride-hail drivers, and delivery fleets. The system, already deployed in dozens of U.S. markets, supplies real-time insights that cities have used to redesign parking policies, as demonstrated by a deployment in Lincoln, Nebraska. By addressing the surge in ride-hailing and e-commerce deliveries, the company aims to make streets safer, more efficient, and more sustainable. Automotus’ business model centers on selling its software and camera hardware to public-sector agencies managing increasingly congested curb space. The company plans to use its newest capital to deepen product capabilities, expand into additional markets, and bolster customer support. Including the latest equity infusion, Automotus has raised $26 million in equity funding to date, alongside the newly secured credit line.

Participated · Series B · Jun 2025

Boost inc builds unattended retail systems that pair connected hardware — smart coolers, vending systems, and self-checkout kiosks — with its flagship cloud platform, Vendlive. The company positions its software as the only solution combining data and revenue insights with point-of-sale management for operators, OEMs, and brands. Boost aims to serve customers where traditional retail and catering models increasingly fail and to become the operating system for unattended retail. The business works with recognizable clients including Coca-Cola, Hilton, and Siemens. Founded in 2020, the company has a 150-person team across London, Zurich and offices in four other countries. Boost plans to use new capital to enter additional international markets, expand its product portfolio, and deepen its technology capabilities.

Participated · Series B · Oct 2023

Microsure develops robot-assisted systems for microsurgery, notably the MUSA-3 which is designed in close cooperation with microsurgeons and engineers. The company says MUSA-3 provides precision for microsurgeons and enables interventions that are virtually impossible to perform by hand. Microsure intends to use the new funding to finalize MUSA-3 development for clinical studies, followed by FDA clearance in the USA and CE-marking in Europe. The company is led by CEO Sjaak Deckers and was founded in 2016 by Eindhoven University of Technology and Maastricht University Medical Center. Microsure is based in Eindhoven, The Netherlands, and currently employs over 30 technical professionals. The recent financing strengthens its position to complete clinical validation and regulatory approvals. Microsure develops robot-assisted systems for microsurgery; its leading product MUSA is the first CE-marked and clinically available surgical robot assistant for open microsurgery. MUSA scales down motion and filters tremor to provide steadier manipulation, targeting procedures such as lymphatic-venous anastomosis, distal nerve repair and vascularized tissue transplantation. The company closed a €2.7 million Series B extension to continue the initial clinical roll-out and to further develop improvements to the system. The planned broader market availability of the improved MUSA system is expected in the course of 2022 after Covid-19 related delays. Microsure was founded in 2016 and is based in Eindhoven; it works with clinical and technical advisors including Maastricht University Medical Center+ as a leading clinical partner.

Led · Equity · Oct 2023

Clarix Imaging is an NIH-funded, venture-backed medical technology company founded by imaging scientists from the University of Chicago that develops point-of-care volumetric specimen imaging. Its flagship, FDA-cleared Volumetric Specimen Imager (VSI-360) is a portable 3D imaging platform that delivers high, isotropic-resolution images with reduced scan times for use in the operating room. The system enables rapid verification of excised tissue during lumpectomies and aims to reduce re-excisions by providing clear margin visualization compatible with surgical workflow. Clarix has commercialized the VSI-360 and reports a surge in demand since commercialization; it is also building a growing library of 3D breast cancer images that could support future AI-driven applications and research. The company plans to use new financing to increase production, broaden clinical use cases beyond breast cancer, and pursue expansion into U.S. and international markets. Financially, Clarix recently received a $10 million financing from kineo finance and is preparing an upcoming equity financing round to further support growth and development.